Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GenovaTSE:9341 -0.97%77 Beneish M-Score is -1.41 as of Jul. 16, 2026. GuruFocus rates TSE:9341 with a GF Score™ of 77/100 and a GF Value™ of 円1,961.82 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 763 Medical Devices & Instruments companies, Genova ranks worse than 88.73% on this metric.
The zones of discrimination for M-Score is as such:
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Warning Sign:
Beneish M-Score -1.41 higher than -1.78, which implies that the company might have manipulated its financial results.
The historical rank and industry rank for Genova's Beneish M-Score or its related term are showing as below:
TSE:9341'
s Beneish M-Score Range Over the Past 10 Years
Min: -2.18 Med: -2.08 Max: -1.41
Current: -1.41
During the past 6 years, the highest Beneish M-Score of Genova was -1.41. The lowest was -2.18. And the median was -2.08.
Genova Beneish M-Score Related Terms
Genova Beneish M-Score Historical Data
* Premium members only.
The historical data trend for Genova's Beneish M-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:9341 vs ABT, SYK, MDT: Beneish M-Score Comparison
For the Medical Devices subindustry, Genova's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genova Beneish M-Score vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Genova's Beneish M-Score distribution charts can be found below:
* The bar in red indicates where Genova's Beneish M-Score falls into.
The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.
The M-Score Variables:
The M-score of Genova for today is based on a combination of the following eight different indices:
M
=
-4.84
+
0.92 * DSRI
+
0.528 * GMI
+
0.404 * AQI
+
0.892 * SGI
+
0.115 * DEPI
=
-4.84
+
0.92 * 0.9952
+
0.528 * 1.3181
+
0.404 * 3.0012
+
0.892 * 1.1559
+
0.115 * 1.1721
-
0.172 * SGAI
+
4.679 * TATA
-
0.327 * LVGI
-
0.172 * 1
+
4.679 * 0.021601
-
0.327 * 1.4903
=
-1.41
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.
DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.
DEPI
=
(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))
/
(Depreciation_t / (Depreciaton_t + PPE_t))
=
(79.95 / (79.95 + 200.821))
/
(143.475 / (143.475 + 447.119))
=
0.284752
/
0.242933
=
1.1721
Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.
6. SGAI = Sales, General and Administrative expenses Index
Total accruals calculated as the change in working capital accounts other than cash less depreciation.
TATA
=
(IncomefromContinuingOperations_t
-
CashFlowsfromOperations_t)
/
TotalAssets_t
=
(NetIncome_t - NonOperatingIncome_t
-
CashFlowsfromOperations_t)
/
TotalAssets_t
=
(275.397 - 0
-
53.855)
/
10255.867
=
0.021601
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Genova has a M-score of -1.41 signals that the company is likely to be a manipulator.
Genova (TSE:9341) has a Beneish M-Score of -1.41 as of Jul. 16, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Genova and its competitors. According to the industry distribution chart, Genova ranks #677 out of 763 companies in the Medical Devices & Instruments industry, placing it in the top 88.7%.
Is Genova's Beneish M-Score too high?
Genova's current Beneish M-Score is -1.41. Based on the distribution chart, Genova ranks #677 out of 763 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Genova has a GF Score™ of 77/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Genova's Beneish M-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Genova ranks #677 out of 763 companies for Beneish M-Score. This places Genova in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Genova and its competitors. Genova's current Beneish M-Score is -1.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genova stock overvalued right now?
Based on GuruFocus' analysis, Genova (TSE:9341) is currently considered Possible Value Trap. The stock's GF Value™ is 円1,961.82, compared to a current price of 円611.00 — trading 68.9% below its estimated fair value. The current Beneish M-Score is -1.41. Genova's overall GF Score™ is 77/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Genova (TSE:9341), the current Beneish M-Score is -1.41 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Genova (TSE:9341) Overvalued in 2026?
Based on GuruFocus' analysis, Genova stock appears to be undervalued.
The current stock price of 円611.00 is trading 68.9% below its estimated GF Value™ of 円1,961.82.
GuruFocus considers Genova to be Possible Value Trap.
Key valuation signals for TSE:9341:
Beneish M-Score: -1.41
GF Value™: 円1,961.82 vs. price of 円611.00 (68.9% below fair value)
No single metric tells the full story. See the TSE:9341 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Genova Inc manages operations of the medical information site and sales of automatic reception and payment machines for clinics. The group operates in two reportable segments: Medical Platform Business and the Smart Clinic Project. The majority of its revenue is generated from the Medical Platform Business, which operates an online media site (Medical Dock) that provides preventive information and health knowledge to users (patients) on diseases and symptoms. In addition, it also supports users in finding a family doctor that suits them. The Smart Clinic Business develops and provides services that improve the convenience and efficiency of non-medical procedures at medical institutions.
77GF Score
Get the complete analysis for TSE:9341
Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9341 has been successfully added to your 
